DURECT Corporation

(DRRX) Trade

By |

Profile

Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories which include new chemical entities and proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, Remoxy, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from the United States.

Contact Information

Website: www.durect.com
Email: mike.arenberg@durect.com
Main Phone: +1 408 777-1417
Address: 10260 Bubb Road
State: CA
City / Town: Cupertino
Country: USA
Postal Code: 95014

Issuer Information

Exchange: NSC
CEO: James E. Brown
Employees: 87
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

Profile

Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories which include new chemical entities and proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, Remoxy, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from the United States.

Contact Information

Website: www.durect.com
Email: mike.arenberg@durect.com
Main Phone: +1 408 777-1417
Address: 10260 Bubb Road
State: CA
City / Town: Cupertino
Country: USA
Postal Code: 95014

Issuer Information

Exchange: NSC
CEO: James E. Brown
Employees: 87
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

$ 2.20 $ 0.07 (3.29%)
Last Price 2.20 Change $ 0.07 Change % 3.29 Tick N/A
Bid 2.19 Bid Size 2,000.00 Ask 2.20 Ask Size 2,600.00
Open 2.14 High 2.25 Low 2.09 Prev Close 2.13
Last Trade Volume 870,675 52 Wk Hi 3.95 52 Wk Low 0.64
Market Cap 431.3 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 196,024,597.00 EPS (TTM) -0.13 PE Ratio N/A Exchange NCM
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 5
Number of Buys 0 5
Number of Sells 0 0
Net Activity 0 145000
Last 10 Buys Shares
David R. Hoffmann 1,000
Felix Theeuwes 1,000
Terrence F. Blaschke 1,000
Armand P. Neukermans 1,000
Armand P. Neukermans 1,000
Felix Theeuwes 1,000
Felix Theeuwes 1,000
Armand P. Neukermans 1,000
Felix Theeuwes 1,000
James E. Brown 1,000
Last 10 Sell Shares
N/A 0
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 6 6 6 6
Low Target Price Estimate 2 2 2 2
Mean Target Price Estimate 3.83 3.83 3.83 3.83
Standard Deviation 2.02 2.02 2.02 2.02
Date of Most Recent Estimate 05/04/18 05/04/18 05/04/18 05/04/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 1 1 1 1
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2 2 2 2